Back P. Roy Vagelos German P. Roy Vagelos Finnish Pindaros Roy Vagelos Portuguese Вагелос, Рой Russian
Roy Vagelos | |
|---|---|
 | |
| Born | Pindaros Roy Vagelos October 8, 1929 |
| Education | University of Pennsylvania (B.A.) Columbia College of Physicians and Surgeons (M.D.) |
| Spouse | Diana Vagelos |
| Awards | Pfizer Award in Enzyme Chemistry (1967) Maxwell Finland Award (1991) Prince Mahidol Award (1997) |
| Scientific career | |
| Fields | Biochemistry, Medicine, Pharmaceutical industry |
Pindaros Roy Vagelos (born October 8, 1929, in Westfield, New Jersey) is an American physician and business executive, who was president and chief executive officer (1985) and chairman (1986) of the American pharmaceutical company Merck & Co. (known as MSD outside the U.S.).
Since 1995, Vagelos has served as chairman of the board of Regeneron Pharmaceuticals.
He was founding chair of the Prix Galien USA awards committee (from 2007 to 2017) and was the first recipient of the Galien Foundation's Pro Bono Humanum Award, which in 2018 was renamed in his honor to the Roy Vagelos Pro Bono Humanum Award for Global Health Equity.[1]
In addition to his business accomplishments, Vagelos is the author of more than 100 scientific papers.[2] He is also on the board of trustees of the University of Pennsylvania and has funded three of the university's elite undergraduate programs: The Vagelos Scholars Program in Molecular Life Sciences (MLS), The Vagelos Program in Life Sciences and Management (LSM) and The Vagelos Integrated Program in Energy Research (VIPER).
- ^ "Committee of prominent health researchers and Nobel laureates renames the Prix Galien Pro Bono Humanum Award to recognize the global health leadership of Dr. Roy Vagelos" (PDF). The Galien Foundation. June 14, 2018.
- ^ The International Who's Who 1991–92. Europa Publ. 1991. ISBN 9780946653706. Retrieved April 12, 2015.